Quarterly report pursuant to Section 13 or 15(d)

9. RELATED PARTY TRANSACTIONS (Details)

v3.10.0.1
9. RELATED PARTY TRANSACTIONS (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Sale and purchase of plasma          
Product revenue $ 4,194,602 $ 4,693,703 $ 12,821,741 $ 10,650,558  
Purchases 9,164,109 11,291,116 31,052,519 17,241,422  
License revenue 35,708 $ 35,708 107,125 $ 107,125  
Accounts receivable 1,005,971   1,005,971   $ 1,245,677
Accounts payable 1,791,354   1,791,354   139,939
Accrued expenses 19,661   19,661   314,820
Note payable, net of discount 14,865,981   14,865,981   14,842,396
Accrued interest 292,500   292,500   65,000
Deferred revenue $ 2,582,908   $ 2,582,908   $ 2,690,033